Clinical Trials Browser

Phase 2 × sagopilone × Dermatologic × Clear all

NCT00598507 2013-12-11

Phase II Trial Of ZK-EPO (ZK 219477) (Sagopilone) In Metastatic Melanoma

Phase 2 Completed

35 enrolled 8 charts

Melanoma